Company Champions Oncology Inc OTC Bulletin Board
Equities
US15870P1093
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
03-15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
03-13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmacology Services
94.1
%
| 47 | 95.4 % | 51 | 94.1 % | +8.27% |
Other Translational Oncology Solutions
5.7
%
| 2 | 4.5 % | 3 | 5.7 % | +36.78% |
Personalized Oncology Services
0.2
%
| 0 | 0.1 % | 0 | 0.2 % | +136.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 49 | 100.0 % | 54 | 100.0 % | +9.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 25/10/10 |
Brady Davis
PSD | President | - | 16/10/23 |
Joel Ackerman
CHM | Chairman | 59 | 25/10/10 |
David Miller
DFI | Director of Finance/CFO | 55 | 31/05/13 |
Karin Heidemann
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/19 |
Maria Mancini
COO | Chief Operating Officer | - | 28/02/15 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 10/04/16 |
Rachel Bunting
IRO | Public Communications Contact | - | - |
Marianna Zipeto
PRN | Corporate Officer/Principal | - | 29/02/20 |
Ido Ben-Zvi
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 31/12/07 |
Scott Tobin
BRD | Director/Board Member | 53 | 26/06/11 |
Joel Ackerman
CHM | Chairman | 59 | 25/10/10 |
Daniel Mendelson
BRD | Director/Board Member | 60 | 28/02/13 |
Ronnie Morris
CEO | Chief Executive Officer | 58 | 25/10/10 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 10/04/16 |
Robert Brainin
BRD | Director/Board Member | 53 | 07/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,714,099 | 10,119,930 ( 73.79 %) | 120,333 ( 0.8774 %) | 73.79 % |
Company contact information
Champions Oncology, Inc.
One University Plaza Suite 307
07601, Hackensack
+201 808 8400
http://www.championsoncology.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- CSBR Stock
- Stock
- Company Champions Oncology Inc